ब्रेन ट्यूमर (ग्लीओमा)

High grade gliomas, particularly glioblastoma, are among the most aggressive brain tumors and are associated with poor outcomes despite standard treatment. Many patients, especially older adults or those with poor general health, are not suitable for surgery and have a life expectancy of less than 12 months. Current standard includes a shortened course of radiotherapy (over 3 weeks) combined with chemotherapy using temozolomide (TMZ), which offers limited survival benefits. This study aims to explore whether delivering radiotherapy in a shorter duration (1 or 2 weeks) at a higher dose, guided …

Sponsor: Tata Memorial Centre
NCT07338539 on ClinicalTrials.gov
शेवटचे अपडेट 18 May 2026 · आम्ही वाचले 20 Oct 2026